Link copied to clipboard
SEC: Fla. drugmaker ripped off worker-owners before sale to Glaxo
Stiefel Labs paid workers and other investors less than $17,000 for their shares, and said it would stay family-owned - then sold to Glaxo for $68,000 a share
Stiefel Labs paid workers and other investors less than $17,000 for their shares, and said it would stay family-owned - then sold to Glaxo for $68,000 a share